Cargando…
Keeping communities at the centre of efforts to eliminate lymphatic filariasis: learning from the past to reach a future free of lymphatic filariasis
Since the launch of the Global Programme to Eliminate Lymphatic Filariasis (GPELF) in 2000, more than 910 million people have received preventive chemotherapy for lymphatic filariasis (LF) and many thousands have received care for chronic manifestations of the disease. To achieve this, millions of c...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753171/ https://www.ncbi.nlm.nih.gov/pubmed/33349882 http://dx.doi.org/10.1093/inthealth/ihaa086 |
_version_ | 1783626015142051840 |
---|---|
author | Krentel, Alison Gyapong, Margaret McFarland, Deborah A Ogundahunsi, Olumide Titaley, Christiana R Addiss, David G |
author_facet | Krentel, Alison Gyapong, Margaret McFarland, Deborah A Ogundahunsi, Olumide Titaley, Christiana R Addiss, David G |
author_sort | Krentel, Alison |
collection | PubMed |
description | Since the launch of the Global Programme to Eliminate Lymphatic Filariasis (GPELF) in 2000, more than 910 million people have received preventive chemotherapy for lymphatic filariasis (LF) and many thousands have received care for chronic manifestations of the disease. To achieve this, millions of community drug distributors (CDDs), community members and health personnel have worked together each year to ensure that at-risk communities receive preventive chemotherapy through mass drug administration (MDA). The successes of 20 y of partnership with communities is celebrated, including the application of community-directed treatment, the use of CDDs and integration with other platforms to improve community access to healthcare. Important challenges facing the GPELF moving forward towards 2030 relate to global demographic, financing and programmatic changes. New innovations in research and practice present opportunities to encourage further community partnership to achieve the elimination of LF as a public health problem. We stress the critical need for community ownership in the current Covid-19 pandemic, to counter concerns in relaunching MDA programmes for LF. |
format | Online Article Text |
id | pubmed-7753171 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-77531712020-12-29 Keeping communities at the centre of efforts to eliminate lymphatic filariasis: learning from the past to reach a future free of lymphatic filariasis Krentel, Alison Gyapong, Margaret McFarland, Deborah A Ogundahunsi, Olumide Titaley, Christiana R Addiss, David G Int Health Review Since the launch of the Global Programme to Eliminate Lymphatic Filariasis (GPELF) in 2000, more than 910 million people have received preventive chemotherapy for lymphatic filariasis (LF) and many thousands have received care for chronic manifestations of the disease. To achieve this, millions of community drug distributors (CDDs), community members and health personnel have worked together each year to ensure that at-risk communities receive preventive chemotherapy through mass drug administration (MDA). The successes of 20 y of partnership with communities is celebrated, including the application of community-directed treatment, the use of CDDs and integration with other platforms to improve community access to healthcare. Important challenges facing the GPELF moving forward towards 2030 relate to global demographic, financing and programmatic changes. New innovations in research and practice present opportunities to encourage further community partnership to achieve the elimination of LF as a public health problem. We stress the critical need for community ownership in the current Covid-19 pandemic, to counter concerns in relaunching MDA programmes for LF. Oxford University Press 2020-12-22 /pmc/articles/PMC7753171/ /pubmed/33349882 http://dx.doi.org/10.1093/inthealth/ihaa086 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Review Krentel, Alison Gyapong, Margaret McFarland, Deborah A Ogundahunsi, Olumide Titaley, Christiana R Addiss, David G Keeping communities at the centre of efforts to eliminate lymphatic filariasis: learning from the past to reach a future free of lymphatic filariasis |
title | Keeping communities at the centre of efforts to eliminate lymphatic filariasis: learning from the past to reach a future free of lymphatic filariasis |
title_full | Keeping communities at the centre of efforts to eliminate lymphatic filariasis: learning from the past to reach a future free of lymphatic filariasis |
title_fullStr | Keeping communities at the centre of efforts to eliminate lymphatic filariasis: learning from the past to reach a future free of lymphatic filariasis |
title_full_unstemmed | Keeping communities at the centre of efforts to eliminate lymphatic filariasis: learning from the past to reach a future free of lymphatic filariasis |
title_short | Keeping communities at the centre of efforts to eliminate lymphatic filariasis: learning from the past to reach a future free of lymphatic filariasis |
title_sort | keeping communities at the centre of efforts to eliminate lymphatic filariasis: learning from the past to reach a future free of lymphatic filariasis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753171/ https://www.ncbi.nlm.nih.gov/pubmed/33349882 http://dx.doi.org/10.1093/inthealth/ihaa086 |
work_keys_str_mv | AT krentelalison keepingcommunitiesatthecentreofeffortstoeliminatelymphaticfilariasislearningfromthepasttoreachafuturefreeoflymphaticfilariasis AT gyapongmargaret keepingcommunitiesatthecentreofeffortstoeliminatelymphaticfilariasislearningfromthepasttoreachafuturefreeoflymphaticfilariasis AT mcfarlanddeboraha keepingcommunitiesatthecentreofeffortstoeliminatelymphaticfilariasislearningfromthepasttoreachafuturefreeoflymphaticfilariasis AT ogundahunsiolumide keepingcommunitiesatthecentreofeffortstoeliminatelymphaticfilariasislearningfromthepasttoreachafuturefreeoflymphaticfilariasis AT titaleychristianar keepingcommunitiesatthecentreofeffortstoeliminatelymphaticfilariasislearningfromthepasttoreachafuturefreeoflymphaticfilariasis AT addissdavidg keepingcommunitiesatthecentreofeffortstoeliminatelymphaticfilariasislearningfromthepasttoreachafuturefreeoflymphaticfilariasis |